Extended resections for hilar cholangiocarcinoma

Area of Science:

• Hepatobiliary surgery
• Surgical oncology
• Gastroenterology

Background:

• Hilar cholangiocarcinoma (Bile duct cancer) surgical resection is the only potentially curative treatment.
• Achieving wide tumor-free margins can be challenging in central bile duct carcinoma resections.

Purpose of the Study:

• To evaluate the impact of different extended resection strategies on radicality and survival for hilar cholangiocarcinomas.
• To identify optimal surgical approaches for achieving complete tumor removal and improving patient outcomes.

Main Methods:

• Retrospective analysis of 95 patients undergoing hilar cholangiocarcinoma resection between 1988 and 1998.
• Comparison of outcomes between standard hilar/hepatic resections and extended procedures like liver transplantation and partial pancreatoduodenectomy (LTPP).

Main Results:

• Surgical radicality (R0 resection) was the strongest predictor of survival (p < 0.001).
• Extended resections, especially LTPP (93% R0 rate) and right trisegmentectomies (65% R0 rate), achieved higher rates of complete tumor removal compared to standard hilar resections (29% R0 rate).
• Right trisegmentectomy combined with portal vein resection demonstrated the highest 5-year survival rate (57%) after R0 resection.

Conclusions:

• Extended resection techniques, including right trisegmentectomies and LTPP, significantly increase the likelihood of achieving R0 resection for hilar cholangiocarcinoma.
• Right trisegmentectomy with portal vein resection aligns best with surgical oncology principles and is the recommended procedure of choice.
• The applicability of LTPP is limited by the need for immunosuppression.